Richard E. Clarkson
Cardiff, WLS, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Multi-site validation of an AI-based biomarker test for determining ER, PR, and HER2 status from H&E-stained breast cancer slides.
Journal: ESMO real world data and digital oncology
Published: April 22, 2026
Pharmacological Inhibition of cFLIP Targets Breast Cancer Stem Cells.
Journal: Journal of cancer treatment & diagnosis
Published: October 13, 2025
H&E-based MSI/MMR testing with AI in colorectal cancer: a multi-centred blinded evaluation.
Journal: NPJ digital medicine
Published: July 30, 2025
New Anticancer 4-Aryldihydropyrimidinone-5-Carboxylates Targeting Hsp90.
Journal: Chemical biology & drug design
Published: July 02, 2025
Inhibition of c-FLIP alongside TRAIL treatment suppresses prostate cancer stem cell activity.
Journal: British journal of cancer
Published: June 04, 2025
Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer.
Journal: Cells
Published: December 22, 2023
Suppression of Bcl3 Disrupts Viability of Breast Cancer Cells through Both p53-Dependent and p53-Independent Mechanisms via Loss of NF-κB Signalling.
Journal: Biomedicines
Published: November 29, 2023
Biodistribution PET/CT Study of Hemoglobin-DFO-89Zr Complex in Healthy and Lung Tumor-Bearing Mice.
Journal: International journal of molecular sciences
Published: July 05, 2020
The Discovery of a Novel Antimetastatic Bcl3 Inhibitor.
Journal: Molecular cancer therapeutics
Published: April 09, 2020
Bcl-3 promotes multi-modal tumour cell migration via NF-κB1 mediated regulation of Cdc42.
Journal: Carcinogenesis
Published: June 24, 2019
Last Updated: 09/26/2026